The global bovine respiratory disease treatment market is expected to rise with an impressive CAGR and generate the highest revenue by 2026.¬†Fortune Business Insights™ in its latest report published this information. The report is titled “Bovine Respiratory Disease Treatment Market Size, Share and Global Trend By Disease (Diphtheria, Lower Respiratory Tract Infection, Upper Respiratory Tract Infection), By Treatment (Vaccinations, Antibiotics, Immunomodulators, Nonsteroidal Anti-Inflammatory Drugs, Others), By End User (Veterinary Hospitals, Veterinary Clinics, Others), and Geography Forecast till 2026”. The report discusses research objectives, research scope, methodology, timeline and challenges during the entire forecast period. It also offers an exclusive insight into various details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies.

For more information, Get sample pdf @

The report provides a 360-degree overview of the market, listing various factors restricting, propelling, and obstructing the market in the forecast duration. The report also provides additional information such as interesting insights, key industry developments, detailed segmentation of the market, list of prominent players operating in the market, and other bovine respiratory disease treatment market trends. The report is available for sale on the company website.

Leading Players operating in the Bovine Respiratory Disease Treatment Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

  • Zoetis
  • Intervet Inc.
  • Virbac
  • Boehringer Ingelheim International GmbH
  • Ceva
  • Elanco
  • Vetoquinol S.A.
  • Bimeda, Inc.
  • Bayer AG
  • And others.

Bovine Respiratory Disease (BRD) refers to one of the most common and expensive diseases to occur to cattle worldwide. The bovine respiratory disease is also called a disease complex, due to the variety of causes such as various pathogens leading to its occurrence in bovines. According to the estimates of the Beef Cattle Research Council, Bovine respiratory disease accounts for 65-80% of the morbidity and 45-75% of the mortality in the feed yards. Bovine respiratory disease occurs due to various infections including viruses, bacteria and parasites viruses, includes bovine herpesvirus (IBR); bovine parainfluenza virus (PI-3), bovine respiratory syncytial virus (BRSV); bovine viral diarrhea virus (BVD), and bovine coronavirus (BCV).

Launch of Respiratory Vaccine by Boehringer Ingelheim International GmbH to propel Business Opportunities

The launch of the Bovalto Respi Intranasal is predicted to enable healthy growth of the market in the forthcoming years. For instance, In September 2018, Boehringer Ingelheim International GmbH. launched Bovalto Respi Intranasal is a new respiratory vaccine for active immunization of cattle against the viruses Parainfluenza 3 Virus (PI3V) and Bovine Respiratory Syncytial Virus (BRSV). Furthermore, the launch of the Whisper Veterinary Stethoscope System is predicted to uplift the bovine respiratory disease treatment market share in the foreseeable future. For instance, In September 2017, Merck Animal Health announced the launch of the Whisper Veterinary Stethoscope System, a tool specifically designed to evaluate lung disease severity and for more accurate diagnosis of bovine respiratory disease (BRD).

Regional Analysis for Bovine Respiratory Disease Treatment Market:

  • North America (the USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

Major Table of Contents for Bovine Respiratory Disease Treatment Market:

  1. Introduction
  2. Executive Summary
  3. Market Dynamics
  4. Key Bovine Respiratory Disease Treatment Market Insights
  5. Global Market Analysis, Insights and Forecast, 2015-2026
  6. North America Market Analysis, Insights and Forecast, 2015-2026
  7. Europe Market Analysis, Insights and Forecast, 2015-2026
  8. Asia Pacific Market Analysis, Insights and Forecast, 2015-2026
  9. The Middle East and Africa Market Analysis, Insights and Forecast, 2015-2026
  10. Latin America Market Analysis, Insights and Forecast, 2015-2026
  11. Competitive Landscape
  12. Global Bovine Respiratory Disease Treatment Market Revenue Share Analysis, By Key Players, 2020
  13. Company Profiles
  14. Conclusion

Other Exclusive Reports:

Cosmeceuticals Market

Orthopedic Devices Market

Femoral Head Prostheses Market

Extra Corporeal Membrane Oxygenation Market

Outpatient Rehabilitation Centers Market

Automated Sample Storage Systems Market

About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Name: Ashwin Arora
Email: [email protected]
Phone: US +1 424 253 0390 / UK +44 2071 939123 / APAC: +91 744 740 1245

Leave a Reply

Your email address will not be published. Required fields are marked *